Syndicate content The Healthcare Sales & Marketing Network
Healthcare Sales & Marketing Network NewsFeed
Updated: 55 min 24 sec ago

Industry Veteran Sherry Korczynski Joins Eagle Pharmaceuticals as Senior Vice President of Marketing

Mon, 01/11/2016 - 15:48
WOODCLIFF LAKE, N.J.--(Healthcare Sales & Marketing Network)--Eagle Pharmaceuticals, Inc. (“Eagle” or the “Company”) (Nasdaq: EGRX) announced today that Sherry Korczynski, a pharmaceutical industry veteran with more than 20 years of experience, will join E...
Biopharmaceuticals, Personnel
Eagle Pharmaceuticals, RYANODEX, dantrolene

Industry Veteran Sherry Korczynski Joins Eagle Pharmaceuticals as Senior Vice President of Marketing

Mon, 01/11/2016 - 15:48
WOODCLIFF LAKE, N.J.--(Healthcare Sales & Marketing Network)--Eagle Pharmaceuticals, Inc. (“Eagle” or the “Company”) (Nasdaq: EGRX) announced today that Sherry Korczynski, a pharmaceutical industry veteran with more than 20 years of experience, will join E...
Biopharmaceuticals, Personnel
Eagle Pharmaceuticals, RYANODEX, dantrolene

Teleflex Acquisition of Nostix, LLC Expands Catheter Tip Placement Solutions

Mon, 01/11/2016 - 15:45
Acquisition Compliments Teleflex’s Existing ARROW Vascular Positioning System (VPS) to now include familiar ECG-only technology for the elimination of chest X-ray Additionally, an alternative system with novel navigation capability is under development ...
Devices, Mergers & Acquisitions
Teleflex, Nostix, peripherally inserted central catheter

Teleflex Acquisition of Nostix, LLC Expands Catheter Tip Placement Solutions

Mon, 01/11/2016 - 15:45
Acquisition Compliments Teleflex’s Existing ARROW Vascular Positioning System (VPS) to now include familiar ECG-only technology for the elimination of chest X-ray Additionally, an alternative system with novel navigation capability is under development ...
Devices, Mergers & Acquisitions
Teleflex, Nostix, peripherally inserted central catheter

INSIGHTEC Announces Changes in Leadership and Appoints a New General Manager

Fri, 01/08/2016 - 17:59
HAIFA, Israel, January 8, 2016 -- (Healthcare Sales & Marketing Network) -- INSIGHTEC announced today that Eyal Zadicario has been appointed General Manager of INSIGHTEC. Eyal will lead the company's Research and Development and Operations. Eyal has been ...
Devices, Personnel
INSIGHTEC, MRgFUS, Exablate Neuro, Essential Tremor

INSIGHTEC Announces Changes in Leadership and Appoints a New General Manager

Fri, 01/08/2016 - 17:59
HAIFA, Israel, January 8, 2016 -- (Healthcare Sales & Marketing Network) -- INSIGHTEC announced today that Eyal Zadicario has been appointed General Manager of INSIGHTEC. Eyal will lead the company's Research and Development and Operations. Eyal has been ...
Devices, Personnel
INSIGHTEC, MRgFUS, Exablate Neuro, Essential Tremor

MDNA Life Sciences Appoints New Management Team Members to Lead Development and Commercialization of Mitochondrial Diagnostic Pipeline

Fri, 01/08/2016 - 17:50
Chris Mitton Appointed Chief Executive Officer; Jack Riccardi Appointed Chief Financial Officer JUPITER, Fla., Jan. 8, 2016 -- (Healthcare Sales & Marketing Network) -- MDNA Life Sciences Inc., a molecular diagnostics company pioneering the development...
Diagnostics, Oncology, Personnel
MDNA Life Sciences, prostate cancer, Mitochondrial Diagnostic

MDNA Life Sciences Appoints New Management Team Members to Lead Development and Commercialization of Mitochondrial Diagnostic Pipeline

Fri, 01/08/2016 - 17:50
Chris Mitton Appointed Chief Executive Officer; Jack Riccardi Appointed Chief Financial Officer JUPITER, Fla., Jan. 8, 2016 -- (Healthcare Sales & Marketing Network) -- MDNA Life Sciences Inc., a molecular diagnostics company pioneering the development...
Diagnostics, Oncology, Personnel
MDNA Life Sciences, prostate cancer, Mitochondrial Diagnostic

Counsyl Appoints Ted Snelgrove as Chief Business Officer

Fri, 01/08/2016 - 14:49
SAN FRANCISCO--(Healthcare Sales & Marketing Network)--Counsyl, a health technology company that offers DNA testing for diseases that can impact men, women and their children, today announced that Ted Snelgrove has joined the company as Chief Business Offi...
Diagnostics, Personnel
Counsyl

Counsyl Appoints Ted Snelgrove as Chief Business Officer

Fri, 01/08/2016 - 14:49
SAN FRANCISCO--(Healthcare Sales & Marketing Network)--Counsyl, a health technology company that offers DNA testing for diseases that can impact men, women and their children, today announced that Ted Snelgrove has joined the company as Chief Business Offi...
Diagnostics, Personnel
Counsyl

Theravance, Inc. Announces Name Change to Innoviva, Inc.

Fri, 01/08/2016 - 13:34
SOUTH SAN FRANCISCO, CA--(Healthcare Sales & Marketing Network) - Theravance, Inc. (NASDAQ: THRX), a healthcare-focused asset management company, today announced that it changed its name to Innoviva, Inc., effective January 7, 2016. In addition to Innoviva...
Biopharmaceuticals
Innoviva, Theravance, RELVAR , BREO , ELLIPTA , ANORO , ELLIPTA

Theravance, Inc. Announces Name Change to Innoviva, Inc.

Fri, 01/08/2016 - 13:34
SOUTH SAN FRANCISCO, CA--(Healthcare Sales & Marketing Network) - Theravance, Inc. (NASDAQ: THRX), a healthcare-focused asset management company, today announced that it changed its name to Innoviva, Inc., effective January 7, 2016. In addition to Innoviva...
Biopharmaceuticals
Innoviva, Theravance, RELVAR , BREO , ELLIPTA , ANORO , ELLIPTA

NewLink Genetics Corporation Appoints Brian Wiley as Chief Commercial Officer

Fri, 01/08/2016 - 13:25
AMES, Iowa, Jan. 08, 2016 -- (Healthcare Sales & Marketing Network) -- NewLink Genetics Corporation (NLNK), a biopharmaceutical company at the forefront of discovering, developing and commercializing novel immuno-oncology product candidates, including both...
Biopharmaceuticals, Oncology, Personnel
NewLink Genetics, immunotherapy, immuno-oncology

NewLink Genetics Corporation Appoints Brian Wiley as Chief Commercial Officer

Fri, 01/08/2016 - 13:25
AMES, Iowa, Jan. 08, 2016 -- (Healthcare Sales & Marketing Network) -- NewLink Genetics Corporation (NLNK), a biopharmaceutical company at the forefront of discovering, developing and commercializing novel immuno-oncology product candidates, including both...
Biopharmaceuticals, Oncology, Personnel
NewLink Genetics, immunotherapy, immuno-oncology

Dr. Rolf Muller Appointed as New CEO of BioFluidica, Inc.

Fri, 01/08/2016 - 13:19
CHAPEL HILL, N.C., Jan. 8, 2016 -- (Healthcare Sales & Marketing Network) -- BioFluidica, Inc. has announced the appointment of Dr. Rolf Muller as their new Chief Executive Officer. He will assume responsibilities immediately and will succeed Dr. Steven S...
Biopharmaceuticals, Oncology, Personnel
BioFluidica, microfluidics

Dr. Rolf Muller Appointed as New CEO of BioFluidica, Inc.

Fri, 01/08/2016 - 13:19
CHAPEL HILL, N.C., Jan. 8, 2016 -- (Healthcare Sales & Marketing Network) -- BioFluidica, Inc. has announced the appointment of Dr. Rolf Muller as their new Chief Executive Officer. He will assume responsibilities immediately and will succeed Dr. Steven S...
Biopharmaceuticals, Oncology, Personnel
BioFluidica, microfluidics

AcelRx Completes Protocol Review with FDA and Plans to Initiate Phase 3 Open-Label Study (IAP312) for Zalviso(TM) in 1Q 2016

Fri, 01/08/2016 - 13:13
REDWOOD CITY, Calif., Jan. 8, 2016 -- (Healthcare Sales & Marketing Network) -- AcelRx Pharmaceuticals, Inc. (ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute pai...
Biopharmaceuticals, FDA
AcelRx Pharmaceuticals, Zalviso, sufentanil, sublingual

AcelRx Completes Protocol Review with FDA and Plans to Initiate Phase 3 Open-Label Study (IAP312) for Zalviso(TM) in 1Q 2016

Fri, 01/08/2016 - 13:13
REDWOOD CITY, Calif., Jan. 8, 2016 -- (Healthcare Sales & Marketing Network) -- AcelRx Pharmaceuticals, Inc. (ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute pai...
Biopharmaceuticals, FDA
AcelRx Pharmaceuticals, Zalviso, sufentanil, sublingual

Guardant Health Secures Series D Financing to Expand the Reach of its Digital Sequencing(TM) Platform in Oncology

Thu, 01/07/2016 - 17:45
OrbiMed leads financing, which includes new and existing investors REDWOOD CITY, Calif., Jan. 7, 2016 -- (Healthcare Sales & Marketing Network) -- Guardant Health, the leader in non-invasive cancer genomic sequencing, today announced it has completed a...
Diagnostics, Oncology, Venture Capital
Guardant Health, cancer genomic sequencing, Guardant360

Guardant Health Secures Series D Financing to Expand the Reach of its Digital Sequencing(TM) Platform in Oncology

Thu, 01/07/2016 - 17:45
OrbiMed leads financing, which includes new and existing investors REDWOOD CITY, Calif., Jan. 7, 2016 -- (Healthcare Sales & Marketing Network) -- Guardant Health, the leader in non-invasive cancer genomic sequencing, today announced it has completed a...
Diagnostics, Oncology, Venture Capital
Guardant Health, cancer genomic sequencing, Guardant360

Contact us     New York    l    Miami    l    Sao Paulo     l    Mexico DF    l    London    l    Hong Kong